Daniel Loeb's ARDT Position Overview
Daniel Loeb (via Third Point LLC) currently holds 75.0K shares of Ardent Health, Inc. (ARDT) worth $0, representing 0.00% of the portfolio. First purchased in 2025-Q2, this recently established position has been held for 2 quarters.
Based on recent 13F filings, Daniel Loeb has initiated a new position in ARDT, representing a fresh investment thesis on this company.
Analysis based on 13F filings available since 2013 Q2
Daniel Loeb's Ardent Health (ARDT) Holding Value Over Time
Track share changes against reported price movement
Quarterly Ardent Health (ARDT) Trades by Daniel Loeb
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2025 | +75,000 | New Buy | 75,000 | $13.66 |
| Q3 2025 | -75,000 | Sold Out | 75,000 | $0.00 |
Daniel Loeb's Ardent Health Investment FAQs
Daniel Loeb first purchased Ardent Health, Inc. (ARDT) in Q2 2025, acquiring 75,000 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Daniel Loeb has held Ardent Health, Inc. (ARDT) for 2 quarters since Q2 2025. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Daniel Loeb's largest addition to Ardent Health, Inc. (ARDT) was in Q2 2025, adding 75,000 shares worth $1.02 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
According to the latest 13F filing for Q3 2025, Daniel Loeb's firm, Third Point LLC, owns 75,000 shares of Ardent Health, Inc. (ARDT), valued at approximately $0. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
As of the Q3 2025 filing, Ardent Health, Inc. (ARDT) represents approximately 0.00% of Daniel Loeb's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Daniel Loeb's peak holding in Ardent Health, Inc. (ARDT) was 75,000 shares, as reported at the end of Q2 2025. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.